0001209191-19-036497.txt : 20190612 0001209191-19-036497.hdr.sgml : 20190612 20190612181140 ACCESSION NUMBER: 0001209191-19-036497 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190610 FILED AS OF DATE: 20190612 DATE AS OF CHANGE: 20190612 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Dhingra Kapil CENTRAL INDEX KEY: 0001456849 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36070 FILM NUMBER: 19894486 MAIL ADDRESS: STREET 1: 39 BLISS AVENUE CITY: TENAFLY STATE: NJ ZIP: 07670 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: FIVE PRIME THERAPEUTICS INC CENTRAL INDEX KEY: 0001175505 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 260038620 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 111 OYSTER POINT BOULEVARD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 415-365-5600 MAIL ADDRESS: STREET 1: 111 OYSTER POINT BOULEVARD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-06-10 0 0001175505 FIVE PRIME THERAPEUTICS INC FPRX 0001456849 Dhingra Kapil 111 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 1 0 0 0 Stock Option (right to buy) 6.09 2019-06-10 4 A 0 15000 0.00 A 2029-06-09 Common Stock 15000 15000 D This option will vest in its entirety on the earlier to occur of (i) June 10, 2020 or (ii) the day before the 2020 annual meeting of stockholders of Five Prime Therapeutics, Inc. (the "Company"), subject to the reporting person's continued service to the Company through such vest date. /s/ Francis Sarena, Attorney-in-fact 2019-06-12